Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis® technology platform. Argos' most advanced product candidate, rocapuldencel-T, is being evaluated in the pivotal ADAPT Phase 3 clinical trial for the treatment of metastatic renal cell carcinoma (mRCC). In addition, rocapuldencel-T is being studied in Phase 2 investigator-initiated clinical trials as neoadjuvant therapy for renal cell carcinoma (RCC) and for the treatment of non-small cell lung cancer (NSCLC). Argos is also developing a separate Arcelis®-based product candidate, AGS-004, for the treatment of human immunodeficiency virus (HIV), which is currently being evaluated in an investigator-initiated Phase 2 clinical trial aimed at HIV eradication in adult patients.
View Top Employees from Argos Therapeutics, Inc. (NASDAQ: ARGS)| Website | http://www.argostherapeutics.com/ |
| Ticker | OTCQB:ARGS |
| Revenue | $1 million |
| Funding | $236.3 million |
| Employees | 87 (41 on RocketReach) |
| Founded | 1997 |
| Address | 4233 Technology Dr, Durham, North Carolina 27704, US |
| Phone | (919) 287-6300 |
| Fax | (919) 287-6301 |
| Technologies |
JavaScript,
HTML,
PHP
+38 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Dendritic cells, Pharmaceuticals, Manufacturing, Science and Engineering, Drug Discovery, HIV, Research, Health Care, Renal Cancer, Therapeutics |
| Web Rank | 5 Million |
| Keywords | Argos Therapeutics, Argos Therapeutics Inc, Argos 2016 Investor Day Presentation |
| Competitors | CaroGen Corporation, Immunicum AB (IMMU), Kiromic Biopharma, Inc., Nouscom AG, Scancell Ltd |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Argos Therapeutics, Inc. (NASDAQ: ARGS) employee's phone or email?
Argos Therapeutics, Inc. (NASDAQ: ARGS) Questions
The Argos Therapeutics, Inc. (NASDAQ: ARGS) annual revenue was $1 million in 2024.
Joan Winterbottom is the Chief Human Resources Officer of Argos Therapeutics, Inc. (NASDAQ: ARGS).
41 people are employed at Argos Therapeutics, Inc. (NASDAQ: ARGS).
Argos Therapeutics, Inc. (NASDAQ: ARGS) is based in Durham, North Carolina.
The NAICS codes for Argos Therapeutics, Inc. (NASDAQ: ARGS) are [33, 541711, 5417, 54171, 54, 541].
The SIC codes for Argos Therapeutics, Inc. (NASDAQ: ARGS) are [283, 28].
Top Argos Therapeutics, Inc. (NASDAQ: ARGS) Employees
-
33
-
1
Related Companies
